French Validation of the CAPTURE Case Finding Tool for Obstructive Respiratory Disease

NCT ID: NCT05654597

Last Updated: 2026-01-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

1002 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-04-01

Study Completion Date

2025-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this multicentre prospective study is to validate CAPTURE as a French case finding tool for undiagnosed patients suffering from obstructive pulmonary disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A large number of healthcare professional across the country will screen participants.

Participants willing to participate will have a short interview, and then will have to answer the 5-item CAPTURE questionnaire. They will be assisted to perform a peak expiratory flow measurement with a portable device. The comparison will be made between the CAPTURE decision and a portable spirometry assessing the presence or not of an obstructive disorder.

Patient screened either by the tool or the spirometry will be addressed to a doctor. Follow-up at 6 months will be set up in order to assess the entry or not of those patients to an approved health care pathway.

At the end of each center's participation, a questionnaire will be sent to all healthcare professionals working on the study, to assess the ease of use of spirometry and the CAPTURE tool and its possible implementation in clinical practice.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Diseases Lung Diseases, Obstructive Obstructive Pulmonary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Participants aged 40 or more, without diagnosis of COPD or asthma

Men and women attending aged 40 or more, without previous diagnosis of chronic obstructive pulmonary disease or asthma.

CAPTURE tool

Intervention Type OTHER

CAPTURE 5-item questionnaire and a selected use of peak expiratory flow measurement.

Spirometry

Intervention Type OTHER

Spirometry performed with a portable device, used for comparison with the CAPTURE tool.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CAPTURE tool

CAPTURE 5-item questionnaire and a selected use of peak expiratory flow measurement.

Intervention Type OTHER

Spirometry

Spirometry performed with a portable device, used for comparison with the CAPTURE tool.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* People aged 40 or more,
* Provision of dated and signed informed consent form,
* Currently being treated by a healthcare professional,
* Patients affiliated to the french social security system.

Exclusion Criteria

* Patients previously diagnosed with COPD or asthma,
* Patients with any condition making them unable to perform spirometry or answer a short questionnaire,
* Patients unable to give free and informed consent.
Minimum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Groupe Hospitalier du Havre

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Groupe Hospitalier du Havre

Le Havre, Normandy, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-A00209-34

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.